title: Continuous ambulatory peritoneal dialysis. Eight years of experience at a single center.
abstract: One hundred and thirty-four patients using continuous ambulatory peritoneal dialysis (CAPD) for a mean time of 23.1 +/- 18.3 months (range, 1-76.6) from a single center are reviewed with respect to biochemistry, hematology, parameters of dialysis efficiency, nutrition, and the nature and frequency of complications. Cumulative patient survival was 90%, 86% and 75% at 1, 2 and 3 years, and survival of patients using this technique was 75%, 62% and 40% at corresponding time intervals with no difference demonstrated in diabetic patients or in those older than 50 years. Biochemical and hematologic parameters were well maintained with peritoneal creatinine clearance increasing and peritoneal protein loss remaining stable with ongoing CAPD. Loss of ultrafiltration, however, accounted for 17.7% of permanent transfers to alternative therapy. Low serum albumin and elevated serum triglyceride concentrations correlated with mortality, whereas low serum albumin, low cholesterol, and high phosphate levels correlated with morbidity as assessed by frequency of hospital admissions. Dietary protein intake assessed by urea generation rate was significantly lower than that estimated from a 24-hour dietary recall (0.82 vs. 1.02 g/kg/day, p less than 0.01) and with the exception of body mass index and serum albumin, anthropometric and visceral protein measurements showed few correlations with nutritional adequacy. Bacterial peritonitis remained the major complication, although fungal infections made a significant contribution to morbidity and mortality. Overall, CAPD is confirmed to be a satisfactory form of dialysis for all forms of end-stage renal failure and an integral part of any renal replacement program. However, nutritional adequacy and lowering of complication rates require further investigation.
authors.affiliation: Department of Renal Medicine, Royal North Shore Hospital, St. Leonards, N.S.W, Australia.
authors.forename: C A
authors.initials: CA
authors.lastname: Pollock
authors.forename: L S
authors.initials: LS
authors.lastname: Ibels
authors.forename: R J
authors.initials: RJ
authors.lastname: Caterson
authors.forename: J F
authors.initials: JF
authors.lastname: Mahony
authors.forename: D A
authors.initials: DA
authors.lastname: Waugh
authors.forename: B
authors.initials: B
authors.lastname: Cocksedge
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D002404:Catheterization / Q000009:adverse effects; D002648:Child; D005260:Female; D006760:Hospitalization; D006801:Humans; D007674:Kidney Diseases / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000209:etiology; D011552:Pseudomonas Infections / Q000209:etiology; D013203:Staphylococcal Infections / Q000209:etiology